XWEL Stock Analysis: Buy, Sell, or Hold?
XWEL - XWELL, Inc. Common Stock
$1.00
-0.04 (-3.85%)
âŧ
5d:
+7.53%
30d:
-4.76%
90d:
-30.56%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When XWEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: XWEL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: XWEL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: XWEL is currently trading at $1.00, which is considered fair relative to its 30-day fair value range of $0.97 to $1.08.
Technical Outlook: Technically, XWEL is in a strong downtrend. Immediate support is located at $0.87, while resistance sits at $1.07. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.00 (+600.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XWEL is in a strong downtrend. Immediate support is located at $0.87, while resistance sits at $1.07. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.00 (+600.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.97 -
$1.08
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 600.0% below Wall St target ($7.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.97 -
$1.08
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.87
Resistance Level
$1.07
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.79
Wall Street Target
$7.00
(+600.0%)
Revenue Growth (YoY)
-7.1%
Profit Margin
-82.9%
Share & Embed Analysis
Last updated: August 24, 2026 5:27 PM ET
Data refreshes hourly during market hours. Next update: 6:27 PM
Data refreshes hourly during market hours. Next update: 6:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XWEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 44 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 37 SELL |